Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults
A novel Staphylococcus aureus 4-antigen vaccine (SA4Ag) is under development, comprising capsular polysaccharide serotypes 5 and 8 (CP5 and CP8) conjugated to CRM197, recombinant protein clumping factor A (rmClfA), and recombinant manganese transporter protein C (MntC). We evaluated SA4Ag safety, to...
Saved in:
Main Authors: | Megumi Inoue (Author), Takuma Yonemura (Author), James Baber (Author), Yasuko Shoji (Author), Masakazu Aizawa (Author), David Cooper (Author), Joseph Eiden (Author), William C. Gruber (Author), Kathrin U. Jansen (Author), Annaliesa S. Anderson (Author), Alejandra Gurtman (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery
by: A. Gurtman, et al.
Published: (2019) -
The role of vaccines in fighting antimicrobial resistance (AMR)
by: Kathrin U. Jansen, et al.
Published: (2018) -
Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles
by: Mei Lu, et al.
Published: (2023) -
Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
by: Fu-Ying Dai, et al.
Published: (2017) -
Vaccination strategies for the prevention of meningococcal disease
by: Scott Vuocolo, et al.
Published: (2018)